[Treatment of genital herpes].
Hiltunen-Back
E
E
HYKS:n iho- ja allergiasairaala Meilahdentie 2, 00250 Helsinki. eija.hiltunen-back@hus.fi
D015075:2-Aminopurine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000212:Acyclovir / Q000031:analogs & derivatives / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D000077595:Famciclovir; D005260:Female; D006558:Herpes Genitalis / Q000188:drug therapy* / Q000517:prevention & control* / Q000635:transmission; D018259:Herpesvirus 1, Human / Q000187:drug effects / Q000302:isolation & purification; D018258:Herpesvirus 2, Human / Q000187:drug effects / Q000302:isolation & purification; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D008297:Male; D010353:Patient Education as Topic; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy* / Q000517:prevention & control*; D055502:Secondary Prevention
D000998:Antiviral Agents; D015075:2-Aminopurine; D000077595:Famciclovir; D000212:Acyclovir